Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardThe anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2Neoplasia: the second decade.Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activityInflammation to cancer: The molecular biology in the pancreas (Review).A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumorsInvolvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinomaRisk factors for pancreatic cancer: underlying mechanisms and potential targets.COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerConcurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia.Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.The role of COX-2 in intestinal inflammation and colorectal cancerDeploying mouse models of pancreatic cancer for chemoprevention studiesSmoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages.Prostaglandins in cancer cell adhesion, migration, and invasionK-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions.Cell intrinsic role of COX-2 in pancreatic cancer developmentThe tobacco carcinogen nitrosamine induces a differential gene expression response in tumour susceptible A/J and resistant C3H mouse lungs.Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse modelTransgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisMechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis.Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice.The War on Cancer rages on.Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer.The growing challenge of obesity and cancer: an inflammatory issue.Pharmacogenomics of cyclooxygenases.Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.Pancreatic cancer cell lines can induce prostaglandin e2 production from human blood mononuclear cells.Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor.Elevated HuR in Pancreas Promotes a Pancreatitis-like Inflammatory Microenvironment that Facilitates Tumor Development.
P2860
Q24628746-CA1E7A61-D5C1-4DC9-B2F2-EF006E875EB5Q28274081-54E54BF1-B0B2-48C2-B5AE-5E214CD25027Q28533258-27DEF6A9-BBEB-4815-9C34-4C70F36E6310Q30484000-73E4EFF1-AD98-4239-AA41-AFFF4FF4A5AAQ33697712-204DB55A-ED48-408C-811F-ED4E4D9D9572Q33727657-230DFB4A-1EB2-4345-884C-20322C953A5EQ33778138-4889E9E0-7D6C-41C9-9E97-2094CCB1314CQ34067846-879E6CA9-0B39-47AB-9C16-1DE3FC80131DQ34246014-820C516C-C89D-483A-A24C-A9372E6404A2Q34400723-50B77908-1106-46AA-92BA-6D10C416FCC7Q34502422-6047B673-3338-4F6A-A3F5-3FEBD297DA73Q34979334-061ED8D0-6E6B-475A-8B3A-8444218480A5Q34979358-245A5975-8A26-4880-B5CD-2FBF1090FBD5Q35091299-03975A64-B2A5-4A36-88E3-5647A749C284Q35184289-9A326D78-8DA4-4566-844E-5743A8509611Q35234704-65603911-4B68-4C07-B735-86A0D5913AC6Q35622126-8E13F176-A991-4F66-BE33-EF6353EC2E3CQ35687807-E5FF295D-E3E4-4B2B-A63D-71758CCC5B8EQ35821653-B87C0A89-1592-4251-9072-9CEDCF9161BFQ36068611-629D8879-EFA5-413A-A7B1-32D40218F57FQ36312997-8B667CE9-C750-4750-BAF2-B06B41CC677FQ36655305-52F2AB56-0FFB-42A1-996F-017BCBE93E5CQ37180312-2800B242-1B2C-460C-9DE5-D769AE9DDA1FQ37215586-341CBC79-AE36-4589-9648-E325A6021235Q37411831-3C3E935C-F20A-4FEE-98B3-F023DBBD0944Q37421292-47F9843A-8C97-4F6D-AA40-9B050470554CQ37423527-6B64AD82-3BAD-4C13-AF1B-4DB8CEF43AF7Q37478602-AD7025A9-7525-488E-8C67-E2B229FE6867Q37628925-A1ADE3EA-9867-4601-8FB6-48E4D1C18891Q37671739-549F48BE-D041-4252-BB7E-62865302C310Q37906706-9BDC1F21-0189-4E48-94C8-7C556D22373CQ38444433-A8CE7A67-F3A0-4C25-BAE6-C9CA998069BDQ39822633-CD664AFC-968C-4E45-8FF2-105F1B0F98EDQ40679145-6DE79D60-70B7-4B53-ADF3-BD7AF10D6590Q41175540-5410876F-19B1-4011-8CC4-C9ADFA6F0667Q42208993-584F79A5-D325-43B9-AE69-0455B02773D8Q42826105-EE1041E9-E478-4A38-8182-71BA4B409301Q43198689-49253E9F-71D0-4AD5-B899-56440CEC8725Q47407066-F490F347-32D0-42AD-85BD-0618F95F04F5
P2860
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Progressive metaplastic and dy ...... clooxygenase-2 overexpression.
@en
type
label
Progressive metaplastic and dy ...... clooxygenase-2 overexpression.
@en
prefLabel
Progressive metaplastic and dy ...... clooxygenase-2 overexpression.
@en
P2093
P2860
P356
P1433
P1476
Progressive metaplastic and dy ...... yclooxygenase-2 overexpression
@en
P2093
Amy I Pavone
Claudio J Conti
Janet Sawicki
Kaoru Kiguchi
Mark J McArthur
Russell D Klein
Susan M Fischer
Toru Kawamoto
P2860
P304
P356
10.1593/NEO.08330
P577
2008-08-01T00:00:00Z